Busra Aydur Puren

Busra Aydur Puren

Auto-generated profile, based on publicly available information

Busra Aydur Puren

Canakkale Onsekiz Mart Univ, Fac Med, Dept Nucl Med, Terzioglu Campus, TR-17020 Canakkale, Turkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
YSYavuz Sami Salihoğlu
Yavuz Sami Salihoğlu
RERabiye Uslu Erdemir
Rabiye Uslu Erdemir
BPBüşra Aydur Püren
Büşra Aydur Püren
SOSemra OZDEMIR
Semra OZDEMIR
CUCaglar Uyulan
Caglar Uyulan
Huseyin Ozan TekinHuseyin Ozan Tekin
Huseyin Ozan Tekin
This study aimed to evaluate the ability of 18fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) radiomic features combined with machine learning methods to distinguish between benign and malignant solitary pulmonary nodules (SPN). Data of 48 patients with SPN detected on 18F-FDG PET/CT scan were evaluated retrospectively. The texture feature extraction from PET/CT images was performed using an open-source application (LIFEx). Deep learning and classical machine learning algorithms were used to build the models. Final diagnosis was confirmed by pathology and follow-up was accepted as the reference. The performances of the models were assessed by the following metrics: Sensitivity, specificity, accuracy, and area under the receiver operator characteristic curve (AUC). The predictive models provided reasonable performance for the differential diagnosis of SPNs (AUCs ~0.81). The accuracy and AUC of the radiomic models were similar to the visual interpretation. However, when compared to the conventional evaluation, the sensitivity of the deep learning model (88% vs. 83%) and specificity of the classic learning model were higher (86% vs. 79%). Machine learning based on 18F-FDG PET/CT texture features can contribute to the conventional evaluation to distinguish between benign and malignant lung nodules.

3 August 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SESema Ekici
Sema Ekici
SOSemra OZDEMIR
Semra OZDEMIR
BPBusra Aydur Puren
Busra Aydur Puren